In conclusion, OAT is an important mediator of mitochondrial ROS generation in lungs affected by IPF, and its inhibition may be a useful novel therapeutic strategy for regulating ECM component production and TGF-β1 activity in IPF. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.